Cargando…

Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070)

PURPOSE/BACKGROUND: The asenapine transdermal system (HP-3070) is the first antipsychotic patch approved in the United States for treatment of adults with schizophrenia. METHODS/PROCEDURES: Three phase 1, open-label, randomized studies characterized the pharmacokinetic (PK) profile of HP-3070 by ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Katsumi, Castelli, Mariacristina, Komaroff, Marina, Starling, Brittney, Terahara, Takaaki, Citrome, Leslie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083160/ https://www.ncbi.nlm.nih.gov/pubmed/33734167 http://dx.doi.org/10.1097/JCP.0000000000001383

Ejemplares similares

M45. EFFICACY AND SAFETY OF THE ASENAPINE TRANSDERMAL PATCH, HP-3070 (SECUADO©), FOR SCHIZOPHRENIA: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, INPATIENT STUDY
Publicado: (2020)

d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyses from a Pivotal Trial
por: Cutler, Andrew J., et al.
Publicado: (2023)

Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study
por: Cutler, Andrew J., et al.
Publicado: (2022)

Role of sublingual asenapine in treatment of schizophrenia
por: Citrome, Leslie
Publicado: (2011)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

Transdermal Asenapine in Schizophrenia: A Systematic Review
por: Carrithers, Brennan, et al.
Publicado: (2020)

Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia
por: Hard, Marjie L., et al.
Publicado: (2017)

Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder
por: Citrome, Leslie, et al.
Publicado: (2017)

Asenapine pharmacokinetics and tolerability in a pediatric population
por: Dogterom, Peter, et al.
Publicado: (2018)

Asenapine for bipolar disorder
por: Scheidemantel, Thomas, et al.
Publicado: (2015)

Boosting the In Vivo Transdermal Bioavailability of Asenapine Maleate Using Novel Lavender Oil-Based Lipid Nanocapsules for Management of Schizophrenia
por: El-Tokhy, Fatma Sa’eed, et al.
Publicado: (2023)

Planeación de la auditoría financiera en cumplimiento con el Boletín 3070 /
por: Hernández Rivera, Eufracia Zoraida
Publicado: (2006)

Continuation rate for asenapine and brexpiprazole treatment in patients with schizophrenia
por: Inoue, Yuichi, et al.
Publicado: (2021)

Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D(2) Receptor Occupancy: Unique Characteristics of Blonanserin Transdermal Patch
por: Tomita, Yoshiko, et al.
Publicado: (2022)

Asenapine, a new sublingual atypical antipsychotic
por: Balaraman, R, et al.
Publicado: (2010)

A Review of Asenapine in the Treatment of Bipolar Disorder
por: Vieta, Eduard, et al.
Publicado: (2017)

Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder
por: Gonzalez, Jodi M, et al.
Publicado: (2011)

Asenapine effects in animal models of psychosis and cognitive function
por: Marston, Hugh M., et al.
Publicado: (2009)

Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada
por: Lachaine, Jean, et al.
Publicado: (2014)

Asenapine augmentation in bipolar disorders: a case series
por: Marazziti, Donatella, et al.
Publicado: (2016)

Treating Borderline personality disorder with Asenapine : Case report
por: Aboelenien, S. K. I. M., et al.
Publicado: (2023)

3070 Time to Diagnostic Resolution After an Abnormal Screening Mammogram: a Single-Center Experience in an Underserved Hospital
por: Kumar, Anita J, et al.
Publicado: (2019)

Weight Change over Ten Years Predicts Biological Aging in a Random Sample of 3070 U.S. Adults
por: Tucker, Larry A., et al.
Publicado: (2023)

Improvement of solubility and pharmacokinetic profile of hepatoprotector icariin through complexation with HP-γ-cyclodextrin
por: Ding, Yili, et al.
Publicado: (2023)

Pharmacokinetics of transdermal buprenorphine patch in the elderly
por: Al-Tawil, Nabil, et al.
Publicado: (2012)

Asenapine modulates nitric oxide release and calcium movements in cardiomyoblasts
por: Grossini, Elena, et al.
Publicado: (2016)

Asenapine-induced double incontinence: A rare case report
por: Singh, Gurvinder Pal, et al.
Publicado: (2014)

Simultaneous determination of asenapine and valproic acid in human plasma using LC–MS/MS: Application of the method to support pharmacokinetic study
por: Reddy, Ambavaram Vijaya Bhaskar, et al.
Publicado: (2013)

Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage: Data From the RIGHT-2 Trial
por: Bath, Philip M., et al.
Publicado: (2019)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
por: Bishara, Delia, et al.
Publicado: (2009)

Supersensitivity Psychosis and Its Response to Asenapine in a Patient with Delusional Disorder
por: Rajkumar, Ravi Philip
Publicado: (2014)

Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine
por: Takao, Nagara, et al.
Publicado: (2021)

The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
por: Pompili, Maurizio, et al.
Publicado: (2011)

Augmentative Asenapine in a Recurrent Manic Catatonic Patient with Partial Response to Clozapine
por: Buoli, Massimiliano, et al.
Publicado: (2013)

New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
por: Warren, Calvert G, et al.
Publicado: (2013)

The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
por: Thomas, Jennifer E., et al.
Publicado: (2015)

Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review
por: Stepanova, Ekaterina, et al.
Publicado: (2017)

Nanovesicles for transdermal delivery of felodipine: Development, characterization, and pharmacokinetics
por: Yusuf, Mohd, et al.
Publicado: (2014)

Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine
por: Buchanan, Beth, et al.
Publicado: (2018)

Pharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation
por: Regenthal, Ralf, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c0stgo5irevk912e3h0om30dru